Recruiting soon

Virtual Reality Assistant for Prostate Cancer Support in Black Men

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Best Practice

+ Discussion

+ Survey Administration

OtherProcedure
Who is being recruted

Urogenital Diseases+7

+ Genital Diseases

+ Genital Diseases, Male

+6 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Supportive Care Study

Interventional
Study Start: March 2026
See protocol details

Summary

Principal SponsorMayo Clinic
Study ContactDee Glaser-BoivinMore contacts
Last updated: January 21, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: March 1, 2026

Actual date on which the first participant was enrolled.

This clinical trial aims to evaluate a new virtual reality tool called PPCD ViRA that supports African American/Black men who have recently been diagnosed with prostate cancer. The study is focused on seeing how well this tool can provide emotional support, help with navigating health-related social challenges, and offer psycho-oncology support. The main goal is to find out if using this virtual reality assistant can reduce emotional distress and improve the well-being of these patients. This research is important because it seeks to address the specific needs of Black men with prostate cancer, potentially offering more personalized and effective support. Participants in the study are divided into two groups. One group starts using the ViRA app immediately, while the other starts after a three-month delay. The ViRA app can be accessed through various devices like a VR headset, smartphone, iPad, or computer. It uses artificial intelligence to provide tailored virtual reality experiences that are culturally relevant and facilitated by digital characters like a prostate cancer survivor or a doctor. Throughout the study, participants' emotional well-being and other outcomes are monitored at several intervals to assess the effectiveness of the intervention. This trial does not mention specific risks, but it aims to enhance the support system for those dealing with a new cancer diagnosis.

Official TitleA Pragmatic Clinical Trial to Evaluate the Effect of a Point of Prostate Cancer Diagnosis (PPCD) Virtual Reality Assistant (ViRA) in Supporting Newly Diagnosed Black Men 
NCT07126548
Principal SponsorMayo Clinic
Study ContactDee Glaser-BoivinMore contacts
Last updated: January 21, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

200 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Supportive Care Study

These studies explore ways to improve comfort and daily life for people living with a condition. They may focus on easing symptoms, reducing treatment side effects, or supporting overall well-being.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Male

Biological sex of participants that are eligible to enroll.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Urogenital DiseasesGenital DiseasesGenital Diseases, MaleGenital Neoplasms, MaleNeoplasmsNeoplasms by SiteProstatic DiseasesProstatic NeoplasmsUrogenital NeoplasmsMale Urogenital Diseases

Criteria

4 inclusion criteria required to participate
African American/Black male
Diagnosed with CaP within two months
Be a patient at a participating clinic or affiliates with one of our community sites
Consent to participating in the study
2 exclusion criteria prevent from participating
Do not speak or understand English
Unable to read or write

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Patients receive standard care and then receive access to the ViRA app (on a VR headset, smartphone, iPAD or computer) and are presented with short screening questions, which an AI engine uses to recommend personalized and culturally tailored VR ready CaP interventions facilitated by a digital human character (CaP survivor, physician, or a psycho-oncologist) 3 months later on study.

Group II

Experimental
Patients receive access to the ViRA app (on a VR headset, smartphone, iPAD or computer) and are presented with short screening questions, which an AI engine uses to recommend personalized and culturally tailored VR ready CaP interventions facilitated by a digital human character (CaP survivor, physician, or a psycho-oncologist) on study.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Mayo Clinic in Florida

Jacksonville, United StatesSee the location
Recruiting soonOne Study Center